The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial
Open accessAbstract
Background: CABANA randomized 2204 patients with atrial fibrillation (AF) to catheter ablation or drug therapy. Analysis by intention-to-treat (ITT), showed a non-significant 14% relative reduction in the primary outcome of death, disabling stroke, serious bleeding, or cardiac arrest. Objective: To assess recurrence of atrial fibrillation (AF) in The Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Methods: We prospectively studied CABANA patients using a proprietary ECG recording monitor for symptom-activated and 24-hour AF auto detection. The AF recurrence endpoint was any post 90-day blanking atrial tachyarrhythmias lasting 30 seconds or longer. Ninety-six-hour Holter monitoring obtained biannually was used to assess AF burden. Patients using the CABANA monitors and provided 90-day post-blanking recordings qualified for this analysis (1240, 56% of CABANA population). Treatment comparisons were performed using a modified- ITT approach. Results: Median age of the 1240 patients was 68 years, 34.4% women, and AF was paroxysmal in 43.0%. Over 60 months of follow-up, first recurrence of any symptomatic or asymptomatic AF (hazard ratio (HR) 0.52, 95% confidence interval (CI) 0.45, 0.60, P<0.001) or, first symptomatic-only AF (HR 0.49, 95% CI 0.39, 0.61, P<0.001) were both significantly reduced in the catheter ablation group. Baseline Holter AF burden in both treatment groups was 48%. At 12 months, AF burden in ablation patients averaged 6.3%, and in drug therapy patients, 14.4%. AF burden was significantly less in catheter ablation compared with drug therapy patients across the 5-year follow-up (P <0.001). These findings were not sensitive to the baseline pattern of AF. Conclusions: Catheter ablation was effective in reducing recurrence of any AF by 48% and symptomatic AF by 51% as compared to drug therapy over 5 years of follow-up. Furthermore, AF burden was also significantly reduced in catheter ablation patients, regardless of their baseline AF type.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290 · cited 1×
“Cumulative incidence estimates using death as a competing risk were derived using Fine-Gray competing risks methodology [16] and graphically depict freedom from recurrence.”
MethodCalkins, H., Hindricks, G., Cappato, R., Kim, Y.-H., Saad, E. B., Aguinaga, L., Akar, J. G., Badhwar, V., Brugada, J., Camm, J., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.012 · Cited by 2,755
Self-citationCalkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
Self-citationBenjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Catheter Ablation for Atrial Fibrillation with Heart Failure
Marrouche, N. F., Brachmann, J., Andresen, D., Siebels, J., Boersma, L., Jordaens, L., Merkely, B., Pokushalov, E., Sanders, P., Proff, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1707855 · Cited by 2,492
Subclinical atrial fibrillation and the risk of stroke
Healey, J. S., Connolly, S. J., Gold, M. R., Israel, C. W., Van Gelder, I. C., Capucci, A., Lau, C. P., Fain, E., Yang, S., Bailleul, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105575 · Cited by 2,100
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-012-9672-7 · Cited by 1,675
Self-citationPacker, D. L., Mark, D. B., Robb, R. A., Monahan, K. H., Bahnson, T. D., Poole, J. E., Noseworthy, P. A., Rosenberg, Y. D., Jeffries, N., Mitchell, L. B., et al. (2019) · JAMA · doi:10.1001/jama.2019.0693 · Cited by 1,503
Self-citationCalkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.12.016 · Cited by 1,456
Self-citation
Cited by
Van Gelder, I. C., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,024
Tzeis, S., Gerstenfeld, E. P., Kalman, J., Saad, E. B., Sepehri Shamloo, A., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Boveda, S., Calkins, H., et al. (2024) · Europace · doi:10.1093/europace/euae043 · Cited by 634
Self-citationAblation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial
Packer, D. L., Piccini, J. P., Monahan, K. H., Al-Khalidi, H. R., Silverstein, A. P., Noseworthy, P. A., Poole, J. E., Bahnson, T. D., Lee, K. L., Mark, D. B., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050991 · Cited by 487
Self-citationTzeis, S., Gerstenfeld, E. P., Kalman, J., Saad, E. B., Shamloo, A. S., Andrade, J. G., Barbhaiya, C. R., Baykaner, T., Boveda, S., Calkins, H., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.03.017 · Cited by 298
Spotlight on the 2024 ESC/EACTS management of atrial fibrillation guidelines: 10 novel key aspects
Rienstra, M., Tzeis, S., Bunting, K. V., Caso, V., Crijns, H. J. G. M., De Potter, T. J. R., Sanders, P., Svennberg, E., Casado-Arroyo, R., Dwight, J., et al. (2024) · Europace · doi:10.1093/europace/euae298 · Cited by 128
Metadata
- Authors
- Poole, J. E., Bahnson, T. D., Monahan, K. H., Johnson, G., Rostami, H., Silverstein, A. P., Al-Khalidi, H. R., Rosenberg, Y., Mark, D. B., Lee, K. L., Packer, D. L., Poole, J. E., Akoum, N., Aoukar, P., Birgersdotter-Green, U., Blatt, J., Cha, Y. M., Chung, M., Gleva, M., Glotzer, T., Henrickson, C., Kron, J., Kuriachan, V., Mulpuru, S., Noseworthy, P., Patton, K., Prutkin, J., Ranjan, R., Rho, R., Russo, A., Stecker, E., Tzou, W., Serdoz, L. V., & Wilson, M.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 75
- Issue
- 25
- Pages
- 3105-3118
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W3036182639
- Cited by
- 268
- References
- 30
- FWCI
- 17.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. https://app.cochat.ai/papers/10.1016/j.jacc.2020.04.065
- The paper
- Poole, J. E., Bahnson, T. D., Monahan, K. H., Johnson, G., Rostami, H., Silverstein, A. P., Al-Khalidi, H. R., Rosenberg, Y., Mark, D. B., Lee, K. L., Packer, D. L., Poole, J. E., Akoum, N., Aoukar, P., Birgersdotter-Green, U., Blatt, J., Cha, Y. M., Chung, M., Gleva, M., . . . Wilson, M. (2020). Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2020.04.065
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.